BIOMAT Database Logo BIOMAT Database Logo

Abstinence treatments for opiate addicts: therapeutic community or naltrexone? 1984

I Arndt, and A T McLellan, and C P O'Brien

UI MeSH Term Description Entries
D008297 Male Males
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013808 Therapeutic Community Psychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients. Community, Therapeutic,Communities, Therapeutic,Therapeutic Communities
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

I Arndt, and A T McLellan, and C P O'Brien
[Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
November 1990, Medicina clinica,
I Arndt, and A T McLellan, and C P O'Brien
Craving in heroin addicts maintained on the opiate antagonist naltrexone.
January 1978, The American journal of drug and alcohol abuse,
I Arndt, and A T McLellan, and C P O'Brien
Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts.
February 1986, Biological psychiatry,
I Arndt, and A T McLellan, and C P O'Brien
Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
May 2017, Addiction (Abingdon, England),
I Arndt, and A T McLellan, and C P O'Brien
[Therapeutic strategy. Replacement treatments for drug addicts].
May 2002, Soins; la revue de reference infirmiere,
I Arndt, and A T McLellan, and C P O'Brien
Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
March 1984, NIDA research monograph,
I Arndt, and A T McLellan, and C P O'Brien
Psychotherapy for opiate addicts.
April 1983, NIDA research monograph,
I Arndt, and A T McLellan, and C P O'Brien
[Use of naltrexone in the treatment of opiate addicts. Efficacy and indications for type categories].
January 1991, La Clinica terapeutica,
I Arndt, and A T McLellan, and C P O'Brien
The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
January 1984, Advances in alcohol & substance abuse,
I Arndt, and A T McLellan, and C P O'Brien
[Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].
January 1993, L'Encephale,
Copied contents to your clipboard!